CYAD

Celyad Oncology (CYAD)

Celyad Oncology SA

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:EU:CYAD

1 2 3 4 5 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/02/09	06:01	GlobeNewswire Inc.	Celyad Oncology announces intention to terminate SEC reporting obligations	EU:CYAD	Celyad Oncology SA
2024/01/17	06:01	GlobeNewswire Inc.	Celyad Oncology provides fourth quarter 2023 business update and 2024 outlook	EU:CYAD	Celyad Oncology SA
2023/12/21	06:01	GlobeNewswire Inc.	Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)	EU:CYAD	Celyad Oncology SA
2023/12/16	06:01	GlobeNewswire Inc.	Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)	EU:CYAD	Celyad Oncology SA
2023/12/05	06:01	GlobeNewswire Inc.	Celyad announces management change	EU:CYAD	Celyad Oncology SA
2023/12/01	20:42	GlobeNewswire Inc.	Publication of a transparency notification received from Tolefi SA (Article 14 §1 of the Law of 2 May 2007)	EU:CYAD	Celyad Oncology SA
2023/11/22	06:00	GlobeNewswire Inc.	Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)	EU:CYAD	Celyad Oncology SA
2023/11/15	06:00	GlobeNewswire Inc.	Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)	EU:CYAD	Celyad Oncology SA
2023/11/09	15:00	GlobeNewswire Inc.	Celyad Oncology reports third quarter 2023 financial results and recent business highlights	EU:CYAD	Celyad Oncology SA
2023/09/26	05:01	GlobeNewswire Inc.	Celyad Oncology announces the termination of its American Depository Receipt program	EU:CYAD	Celyad Oncology SA
2023/09/16	05:01	GlobeNewswire Inc.	Publication of a rectified transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)	EU:CYAD	Celyad Oncology SA
2023/09/13	05:01	GlobeNewswire Inc.	Publication of a transparency notification received from Tolefi SA (Article 14 §1 of the Law of 2 May 2007)	EU:CYAD	Celyad Oncology SA
2023/09/08	05:01	GlobeNewswire Inc.	Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)	EU:CYAD	Celyad Oncology SA
2023/09/06	05:00	GlobeNewswire Inc.	Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)	EU:CYAD	Celyad Oncology SA
2023/09/05	05:00	GlobeNewswire Inc.	Celyad Oncology Reports First Half 2023 Financial Results and Recent Business Highlights	EU:CYAD	Celyad Oncology SA
2023/08/25	05:00	GlobeNewswire Inc.	Celyad Oncology receives approximately EUR 9.8m in private placement commitments from historical shareholders	EU:CYAD	Celyad Oncology SA
2023/05/16	05:01	GlobeNewswire Inc.	Celyad Oncology announces receipt of Nasdaq delisting notice	EU:CYAD	Celyad Oncology SA
2023/05/05	14:00	GlobeNewswire Inc.	Celyad Oncology Announces Intent to Voluntarily Delist American Depository Shares From Nasdaq	EU:CYAD	Celyad Oncology SA
2023/05/05	14:00	GlobeNewswire Inc.	Celyad Oncology reports first quarter 2023 financial results and recent business highlights	EU:CYAD	Celyad Oncology SA
2023/04/25	05:01	GlobeNewswire Inc.	Celyad Oncology announces receipt of Nasdaq initial notification on ADS bid price	EU:CYAD	Celyad Oncology SA
2023/04/05	05:01	GlobeNewswire Inc.	Celyad Oncology announces receipt of Nasdaq notice	EU:CYAD	Celyad Oncology SA
2023/03/24	15:00	GlobeNewswire Inc.	Celyad Oncology appoints Georges Rawadi as its new CEO	EU:CYAD	Celyad Oncology SA
2023/03/24	06:01	GlobeNewswire Inc.	Celyad Oncology reports full year 2022 financial results and recent business highlights	EU:CYAD	Celyad Oncology SA
2023/03/18	06:01	GlobeNewswire Inc.	Celyad Oncology to announce full year 2022 financial results and host conference call	EU:CYAD	Celyad Oncology SA
2023/03/15	15:00	GlobeNewswire Inc.	Celyad Oncology announces non-cash impairment	EU:CYAD	Celyad Oncology SA
2023/03/01	15:00	GlobeNewswire Inc.	REPEAT -- Celyad Oncology SA - Letter to Shareholders	EU:CYAD	Celyad Oncology SA
2023/03/01	01:16	GlobeNewswire Inc.	Celyad Oncology SA - Letter to Shareholders	EU:CYAD	Celyad Oncology SA
2023/02/09	15:00	GlobeNewswire Inc.	Celyad Oncology announces the publication of data from its Phase 1 THINK study of CYAD-01	EU:CYAD	Celyad Oncology SA
2023/02/03	15:00	GlobeNewswire Inc.	Celyad Oncology provides fourth quarter 2022 business update and 2023 outlook	EU:CYAD	Celyad Oncology SA
2022/12/21	15:00	GlobeNewswire Inc.	Celyad Oncology provides an update on its strategic business model, continuing to focus on opportunities to fully harness the true potential of its proprietary technology platforms and intellectual property	EU:CYAD	Celyad Oncology SA